Taiwan-Linked Biotech Fund Raises S$70 Million in First Close

A report published during the November 2–8 period said NeoSci Ventures secured S$70 million in the first close of its debut fund, with backing that included Taiwan’s National Development Fund and Catcher Technology. The fund is intended to invest in biotechnology companies across Asia and the United States. This creates potential opportunities for biotech startups, research partners and specialist service providers.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.